Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting (NCT06712563)
Pooled Analysis of Multi-country, Open-label Single-arm, Non-interventional, Multi-center, Cohort Studies of Real-world Outcomes in New Users of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
🩺 Plain-English Summary (8th-Grade Level)
The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.
Who can join: Review the eligibility criteria below.
Location: Research Site — Mississauga
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Research Site — Mississauga,
- Research Site — Hamburg,
- Research Site — Athens,
- Research Site — Milan,
- Research Site — Tokyo,
- Research Site — Bucharest,
- Research Site — London,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pulmonary Disease, Chronic Obstructive
- Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) — Birmingham, Alabama
- A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease — Yuma, Arizona
- Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent — Rochester, Minnesota
- Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD — Minneapolis, Minnesota
- Innate Immunity in Ozone-induced Airway Inflammation in COPD — San Francisco, California
Explore by condition: All Pulmonary Disease, Chronic Obstructive clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.